UB Paderborn / Katalog / Suche / in CDI

1 – 14 von 14

Sortiert nach

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Molecular cancer therapeutics, 2006-07, Vol.5 (7), p.1854-1863

2006

Volltextzugriff (PDF)

Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications

Methods in molecular biology (Clifton, N.J.), 2014-01, Vol.1141, p.109

2014

Volltextzugriff (PDF)

Current Status and Future Perspectives on MRNA Drug Manufacturing

Molecular pharmaceutics, 2022-04, Vol.19 (4), p.1047-1058

2022

Volltextzugriff (PDF)

Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors

Clinical cancer research, 2008-02, Vol.14 (4), p.1208-1217

2008

Volltextzugriff (PDF)

Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection

Methods in molecular biology (Clifton, N.J.), 2018-01, Vol.1792, p.193

2018

Volltextzugriff (PDF)

Liposomal irinotecan: Formulation development and therapeutic assessment in murine xenograft models of colorectal cancer

Clinical cancer research, 2004-10, Vol.10 (19), p.6638-6649

2004

Volltextzugriff (PDF)

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations

Current drug delivery, 2005-10, Vol.2 (4), p.341

2005

Volltextzugriff (PDF)

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway : therapeutic implications for combination therapy with rapamycin

Breast cancer research and treatment, 2007-12, Vol.106 (3), p.319-331

2007

Volltextzugriff (PDF)

Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems

Current gene therapy, 2006-08, Vol.6 (4), p.505

2006

Volltextzugriff (PDF)

Liposomal Irinotecan

Clinical cancer research, 2004-10, Vol.10 (19), p.6638-6649

2004

Volltextzugriff (PDF)

Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs

Infection and Immunity, 2005-09, Vol.73 (9), p.5782-5788

2005

Volltextzugriff (PDF)

Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model

BMJ (Online), 2022-07, Vol.378, p.e070379

2022

Volltextzugriff (PDF)

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

Clinical cancer research, 2008-11, Vol.14 (22), p.7260-7271

2008

Volltextzugriff (PDF)

Lipid/Polymer Nanoparticles as Tools to Improve the Therapeutic Activity of Existing and Emerging Anticancer Drug Combinations

2004 International Conference on MEMS, NANO and Smart Systems (ICMENS'04), 2004, p.496-496

2004

Volltextzugriff (PDF)

1 – 14 von 14

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(11)
Mit Volltextzugriff
(9)

Publikationsform

Artikel
(13)
Tagungsberichte
(1)

Sprache

Englisch
(14)
Japanisch
(2)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice

Microfluidic-based manufacture of siRNA-lipid nanoparticles for therapeutic applications

Current Status and Future Perspectives on MRNA Drug Manufacturing

Irinophore C: A Liposome Formulation of Irinotecan with Substantially Improved Therapeutic Efficacy against a Panel of Human Xenograft Tumors

Microfluidic Production and Application of Lipid Nanoparticles for Nucleic Acid Transfection

Liposomal irinotecan: Formulation development and therapeutic assessment in murine xenograft models of colorectal cancer

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations

Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway : therapeutic implications for combination therapy with rapamycin

Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems

Liposomal Irinotecan

Pulmonary Interleukin-23 Gene Delivery Increases Local T-Cell Immunity and Controls Growth of Mycobacterium tuberculosis in the Lungs

Burden of SARS-CoV-2 infection in healthcare workers during second wave in England and impact of vaccines: prospective multicentre cohort study (SIREN) and mathematical model

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

Lipid/Polymer Nanoparticles as Tools to Improve the Therapeutic Activity of Existing and Emerging Anticancer Drug Combinations

Suchergebnisse filtern